Global Biological Inactivated Vaccine Market Research Report 2026(Status and Outlook)
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Biological Inactivated Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.Inactivated biological vaccines refer to a type of vaccine that uses physical or chemical methods (such as heat treatment, formaldehyde, ?-propiolactone, etc.) to completely kill pathogenic microorganisms (such as viruses, bacteria, etc.), making them lose their infectivity and pathogenicity, while retaining their main antigenic structure to induce the body to produce a specific immune response. This type of vaccine is highly safe and suitable for people with weak immunity. It is widely used to prevent hepatitis A, polio, rabies, new coronavirus and other infectious diseases.
The global Biological Inactivated Vaccine market size was estimated at USD 892.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Biological Inactivated Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Biological Inactivated Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Biological Inactivated Vaccine market.
Global Biological Inactivated Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi
GSK
Merck
Pfizer
SII
Valneva
Bharat Biotech
KM Biologics
Baxter
Bio Farma
IVAC
Takeda
Emergent BioSolutions
Sinergium Biotech
China Biotechnology
Sinovac
Kangtai Biological
Zhifei Biological
AIM Vaccine
Market Segmentation (by Type)
Inactivated Virus Vaccine
Inactivated Bacterial Vaccine
Market Segmentation (by Application)
Humans
Animals
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biological Inactivated Vaccine Market
Overview of the regional outlook of the Biological Inactivated Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biological Inactivated Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biological Inactivated Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Biological Inactivated Vaccine market size was estimated at USD 892.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Biological Inactivated Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Biological Inactivated Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Biological Inactivated Vaccine market.
Global Biological Inactivated Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi
GSK
Merck
Pfizer
SII
Valneva
Bharat Biotech
KM Biologics
Baxter
Bio Farma
IVAC
Takeda
Emergent BioSolutions
Sinergium Biotech
China Biotechnology
Sinovac
Kangtai Biological
Zhifei Biological
AIM Vaccine
Market Segmentation (by Type)
Inactivated Virus Vaccine
Inactivated Bacterial Vaccine
Market Segmentation (by Application)
Humans
Animals
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biological Inactivated Vaccine Market
Overview of the regional outlook of the Biological Inactivated Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biological Inactivated Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biological Inactivated Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Biological Inactivated Vaccine
1.2 Key Market Segments
1.2.1 Biological Inactivated Vaccine Segment by Type
1.2.2 Biological Inactivated Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOLOGICAL INACTIVATED VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biological Inactivated Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Biological Inactivated Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOLOGICAL INACTIVATED VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Biological Inactivated Vaccine Product Life Cycle
3.3 Global Biological Inactivated Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Biological Inactivated Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Biological Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Biological Inactivated Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Biological Inactivated Vaccine Market Competitive Situation and Trends
3.8.1 Biological Inactivated Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Biological Inactivated Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 BIOLOGICAL INACTIVATED VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Biological Inactivated Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOLOGICAL INACTIVATED VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Biological Inactivated Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Biological Inactivated Vaccine Market
5.7 ESG Ratings of Leading Companies
6 BIOLOGICAL INACTIVATED VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biological Inactivated Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Biological Inactivated Vaccine Market Size by Type (2020-2025)
6.4 Global Biological Inactivated Vaccine Price by Type (2020-2025)
7 BIOLOGICAL INACTIVATED VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biological Inactivated Vaccine Market Sales by Application (2020-2025)
7.3 Global Biological Inactivated Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Biological Inactivated Vaccine Sales Growth Rate by Application (2020-2025)
8 BIOLOGICAL INACTIVATED VACCINE MARKET SALES BY REGION
8.1 Global Biological Inactivated Vaccine Sales by Region
8.1.1 Global Biological Inactivated Vaccine Sales by Region
8.1.2 Global Biological Inactivated Vaccine Sales Market Share by Region
8.2 Global Biological Inactivated Vaccine Market Size by Region
8.2.1 Global Biological Inactivated Vaccine Market Size by Region
8.2.2 Global Biological Inactivated Vaccine Market Size by Region
8.3 North America
8.3.1 North America Biological Inactivated Vaccine Sales by Country
8.3.2 North America Biological Inactivated Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Biological Inactivated Vaccine Sales by Country
8.4.2 Europe Biological Inactivated Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Biological Inactivated Vaccine Sales by Region
8.5.2 Asia Pacific Biological Inactivated Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Biological Inactivated Vaccine Sales by Country
8.6.2 South America Biological Inactivated Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Biological Inactivated Vaccine Sales by Region
8.7.2 Middle East and Africa Biological Inactivated Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 BIOLOGICAL INACTIVATED VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Biological Inactivated Vaccine by Region(2020-2025)
9.2 Global Biological Inactivated Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Biological Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Biological Inactivated Vaccine Production
9.4.1 North America Biological Inactivated Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Biological Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Biological Inactivated Vaccine Production
9.5.1 Europe Biological Inactivated Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Biological Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Biological Inactivated Vaccine Production (2020-2025)
9.6.1 Japan Biological Inactivated Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Biological Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Biological Inactivated Vaccine Production (2020-2025)
9.7.1 China Biological Inactivated Vaccine Production Growth Rate (2020-2025)
9.7.2 China Biological Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Biological Inactivated Vaccine Product Overview
10.1.3 Sanofi Biological Inactivated Vaccine Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Biological Inactivated Vaccine Product Overview
10.2.3 GSK Biological Inactivated Vaccine Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Merck
10.3.1 Merck Basic Information
10.3.2 Merck Biological Inactivated Vaccine Product Overview
10.3.3 Merck Biological Inactivated Vaccine Product Market Performance
10.3.4 Merck Business Overview
10.3.5 Merck SWOT Analysis
10.3.6 Merck Recent Developments
10.4 Pfizer
10.4.1 Pfizer Basic Information
10.4.2 Pfizer Biological Inactivated Vaccine Product Overview
10.4.3 Pfizer Biological Inactivated Vaccine Product Market Performance
10.4.4 Pfizer Business Overview
10.4.5 Pfizer Recent Developments
10.5 SII
10.5.1 SII Basic Information
10.5.2 SII Biological Inactivated Vaccine Product Overview
10.5.3 SII Biological Inactivated Vaccine Product Market Performance
10.5.4 SII Business Overview
10.5.5 SII Recent Developments
10.6 Valneva
10.6.1 Valneva Basic Information
10.6.2 Valneva Biological Inactivated Vaccine Product Overview
10.6.3 Valneva Biological Inactivated Vaccine Product Market Performance
10.6.4 Valneva Business Overview
10.6.5 Valneva Recent Developments
10.7 Bharat Biotech
10.7.1 Bharat Biotech Basic Information
10.7.2 Bharat Biotech Biological Inactivated Vaccine Product Overview
10.7.3 Bharat Biotech Biological Inactivated Vaccine Product Market Performance
10.7.4 Bharat Biotech Business Overview
10.7.5 Bharat Biotech Recent Developments
10.8 KM Biologics
10.8.1 KM Biologics Basic Information
10.8.2 KM Biologics Biological Inactivated Vaccine Product Overview
10.8.3 KM Biologics Biological Inactivated Vaccine Product Market Performance
10.8.4 KM Biologics Business Overview
10.8.5 KM Biologics Recent Developments
10.9 Baxter
10.9.1 Baxter Basic Information
10.9.2 Baxter Biological Inactivated Vaccine Product Overview
10.9.3 Baxter Biological Inactivated Vaccine Product Market Performance
10.9.4 Baxter Business Overview
10.9.5 Baxter Recent Developments
10.10 Bio Farma
10.10.1 Bio Farma Basic Information
10.10.2 Bio Farma Biological Inactivated Vaccine Product Overview
10.10.3 Bio Farma Biological Inactivated Vaccine Product Market Performance
10.10.4 Bio Farma Business Overview
10.10.5 Bio Farma Recent Developments
10.11 IVAC
10.11.1 IVAC Basic Information
10.11.2 IVAC Biological Inactivated Vaccine Product Overview
10.11.3 IVAC Biological Inactivated Vaccine Product Market Performance
10.11.4 IVAC Business Overview
10.11.5 IVAC Recent Developments
10.12 Takeda
10.12.1 Takeda Basic Information
10.12.2 Takeda Biological Inactivated Vaccine Product Overview
10.12.3 Takeda Biological Inactivated Vaccine Product Market Performance
10.12.4 Takeda Business Overview
10.12.5 Takeda Recent Developments
10.13 Emergent BioSolutions
10.13.1 Emergent BioSolutions Basic Information
10.13.2 Emergent BioSolutions Biological Inactivated Vaccine Product Overview
10.13.3 Emergent BioSolutions Biological Inactivated Vaccine Product Market Performance
10.13.4 Emergent BioSolutions Business Overview
10.13.5 Emergent BioSolutions Recent Developments
10.14 Sinergium Biotech
10.14.1 Sinergium Biotech Basic Information
10.14.2 Sinergium Biotech Biological Inactivated Vaccine Product Overview
10.14.3 Sinergium Biotech Biological Inactivated Vaccine Product Market Performance
10.14.4 Sinergium Biotech Business Overview
10.14.5 Sinergium Biotech Recent Developments
10.15 China Biotechnology
10.15.1 China Biotechnology Basic Information
10.15.2 China Biotechnology Biological Inactivated Vaccine Product Overview
10.15.3 China Biotechnology Biological Inactivated Vaccine Product Market Performance
10.15.4 China Biotechnology Business Overview
10.15.5 China Biotechnology Recent Developments
10.16 Sinovac
10.16.1 Sinovac Basic Information
10.16.2 Sinovac Biological Inactivated Vaccine Product Overview
10.16.3 Sinovac Biological Inactivated Vaccine Product Market Performance
10.16.4 Sinovac Business Overview
10.16.5 Sinovac Recent Developments
10.17 Kangtai Biological
10.17.1 Kangtai Biological Basic Information
10.17.2 Kangtai Biological Biological Inactivated Vaccine Product Overview
10.17.3 Kangtai Biological Biological Inactivated Vaccine Product Market Performance
10.17.4 Kangtai Biological Business Overview
10.17.5 Kangtai Biological Recent Developments
10.18 Zhifei Biological
10.18.1 Zhifei Biological Basic Information
10.18.2 Zhifei Biological Biological Inactivated Vaccine Product Overview
10.18.3 Zhifei Biological Biological Inactivated Vaccine Product Market Performance
10.18.4 Zhifei Biological Business Overview
10.18.5 Zhifei Biological Recent Developments
10.19 AIM Vaccine
10.19.1 AIM Vaccine Basic Information
10.19.2 AIM Vaccine Biological Inactivated Vaccine Product Overview
10.19.3 AIM Vaccine Biological Inactivated Vaccine Product Market Performance
10.19.4 AIM Vaccine Business Overview
10.19.5 AIM Vaccine Recent Developments
11 BIOLOGICAL INACTIVATED VACCINE MARKET FORECAST BY REGION
11.1 Global Biological Inactivated Vaccine Market Size Forecast
11.2 Global Biological Inactivated Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Biological Inactivated Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Biological Inactivated Vaccine Market Size Forecast by Region
11.2.4 South America Biological Inactivated Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Biological Inactivated Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Biological Inactivated Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Biological Inactivated Vaccine by Type (2026-2035)
12.1.2 Global Biological Inactivated Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Biological Inactivated Vaccine by Type (2026-2035)
12.2 Global Biological Inactivated Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Biological Inactivated Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Biological Inactivated Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Biological Inactivated Vaccine
1.2 Key Market Segments
1.2.1 Biological Inactivated Vaccine Segment by Type
1.2.2 Biological Inactivated Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOLOGICAL INACTIVATED VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biological Inactivated Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Biological Inactivated Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOLOGICAL INACTIVATED VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Biological Inactivated Vaccine Product Life Cycle
3.3 Global Biological Inactivated Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Biological Inactivated Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Biological Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Biological Inactivated Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Biological Inactivated Vaccine Market Competitive Situation and Trends
3.8.1 Biological Inactivated Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Biological Inactivated Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 BIOLOGICAL INACTIVATED VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Biological Inactivated Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOLOGICAL INACTIVATED VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Biological Inactivated Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Biological Inactivated Vaccine Market
5.7 ESG Ratings of Leading Companies
6 BIOLOGICAL INACTIVATED VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biological Inactivated Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Biological Inactivated Vaccine Market Size by Type (2020-2025)
6.4 Global Biological Inactivated Vaccine Price by Type (2020-2025)
7 BIOLOGICAL INACTIVATED VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biological Inactivated Vaccine Market Sales by Application (2020-2025)
7.3 Global Biological Inactivated Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Biological Inactivated Vaccine Sales Growth Rate by Application (2020-2025)
8 BIOLOGICAL INACTIVATED VACCINE MARKET SALES BY REGION
8.1 Global Biological Inactivated Vaccine Sales by Region
8.1.1 Global Biological Inactivated Vaccine Sales by Region
8.1.2 Global Biological Inactivated Vaccine Sales Market Share by Region
8.2 Global Biological Inactivated Vaccine Market Size by Region
8.2.1 Global Biological Inactivated Vaccine Market Size by Region
8.2.2 Global Biological Inactivated Vaccine Market Size by Region
8.3 North America
8.3.1 North America Biological Inactivated Vaccine Sales by Country
8.3.2 North America Biological Inactivated Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Biological Inactivated Vaccine Sales by Country
8.4.2 Europe Biological Inactivated Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Biological Inactivated Vaccine Sales by Region
8.5.2 Asia Pacific Biological Inactivated Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Biological Inactivated Vaccine Sales by Country
8.6.2 South America Biological Inactivated Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Biological Inactivated Vaccine Sales by Region
8.7.2 Middle East and Africa Biological Inactivated Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 BIOLOGICAL INACTIVATED VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Biological Inactivated Vaccine by Region(2020-2025)
9.2 Global Biological Inactivated Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Biological Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Biological Inactivated Vaccine Production
9.4.1 North America Biological Inactivated Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Biological Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Biological Inactivated Vaccine Production
9.5.1 Europe Biological Inactivated Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Biological Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Biological Inactivated Vaccine Production (2020-2025)
9.6.1 Japan Biological Inactivated Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Biological Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Biological Inactivated Vaccine Production (2020-2025)
9.7.1 China Biological Inactivated Vaccine Production Growth Rate (2020-2025)
9.7.2 China Biological Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Biological Inactivated Vaccine Product Overview
10.1.3 Sanofi Biological Inactivated Vaccine Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Biological Inactivated Vaccine Product Overview
10.2.3 GSK Biological Inactivated Vaccine Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Merck
10.3.1 Merck Basic Information
10.3.2 Merck Biological Inactivated Vaccine Product Overview
10.3.3 Merck Biological Inactivated Vaccine Product Market Performance
10.3.4 Merck Business Overview
10.3.5 Merck SWOT Analysis
10.3.6 Merck Recent Developments
10.4 Pfizer
10.4.1 Pfizer Basic Information
10.4.2 Pfizer Biological Inactivated Vaccine Product Overview
10.4.3 Pfizer Biological Inactivated Vaccine Product Market Performance
10.4.4 Pfizer Business Overview
10.4.5 Pfizer Recent Developments
10.5 SII
10.5.1 SII Basic Information
10.5.2 SII Biological Inactivated Vaccine Product Overview
10.5.3 SII Biological Inactivated Vaccine Product Market Performance
10.5.4 SII Business Overview
10.5.5 SII Recent Developments
10.6 Valneva
10.6.1 Valneva Basic Information
10.6.2 Valneva Biological Inactivated Vaccine Product Overview
10.6.3 Valneva Biological Inactivated Vaccine Product Market Performance
10.6.4 Valneva Business Overview
10.6.5 Valneva Recent Developments
10.7 Bharat Biotech
10.7.1 Bharat Biotech Basic Information
10.7.2 Bharat Biotech Biological Inactivated Vaccine Product Overview
10.7.3 Bharat Biotech Biological Inactivated Vaccine Product Market Performance
10.7.4 Bharat Biotech Business Overview
10.7.5 Bharat Biotech Recent Developments
10.8 KM Biologics
10.8.1 KM Biologics Basic Information
10.8.2 KM Biologics Biological Inactivated Vaccine Product Overview
10.8.3 KM Biologics Biological Inactivated Vaccine Product Market Performance
10.8.4 KM Biologics Business Overview
10.8.5 KM Biologics Recent Developments
10.9 Baxter
10.9.1 Baxter Basic Information
10.9.2 Baxter Biological Inactivated Vaccine Product Overview
10.9.3 Baxter Biological Inactivated Vaccine Product Market Performance
10.9.4 Baxter Business Overview
10.9.5 Baxter Recent Developments
10.10 Bio Farma
10.10.1 Bio Farma Basic Information
10.10.2 Bio Farma Biological Inactivated Vaccine Product Overview
10.10.3 Bio Farma Biological Inactivated Vaccine Product Market Performance
10.10.4 Bio Farma Business Overview
10.10.5 Bio Farma Recent Developments
10.11 IVAC
10.11.1 IVAC Basic Information
10.11.2 IVAC Biological Inactivated Vaccine Product Overview
10.11.3 IVAC Biological Inactivated Vaccine Product Market Performance
10.11.4 IVAC Business Overview
10.11.5 IVAC Recent Developments
10.12 Takeda
10.12.1 Takeda Basic Information
10.12.2 Takeda Biological Inactivated Vaccine Product Overview
10.12.3 Takeda Biological Inactivated Vaccine Product Market Performance
10.12.4 Takeda Business Overview
10.12.5 Takeda Recent Developments
10.13 Emergent BioSolutions
10.13.1 Emergent BioSolutions Basic Information
10.13.2 Emergent BioSolutions Biological Inactivated Vaccine Product Overview
10.13.3 Emergent BioSolutions Biological Inactivated Vaccine Product Market Performance
10.13.4 Emergent BioSolutions Business Overview
10.13.5 Emergent BioSolutions Recent Developments
10.14 Sinergium Biotech
10.14.1 Sinergium Biotech Basic Information
10.14.2 Sinergium Biotech Biological Inactivated Vaccine Product Overview
10.14.3 Sinergium Biotech Biological Inactivated Vaccine Product Market Performance
10.14.4 Sinergium Biotech Business Overview
10.14.5 Sinergium Biotech Recent Developments
10.15 China Biotechnology
10.15.1 China Biotechnology Basic Information
10.15.2 China Biotechnology Biological Inactivated Vaccine Product Overview
10.15.3 China Biotechnology Biological Inactivated Vaccine Product Market Performance
10.15.4 China Biotechnology Business Overview
10.15.5 China Biotechnology Recent Developments
10.16 Sinovac
10.16.1 Sinovac Basic Information
10.16.2 Sinovac Biological Inactivated Vaccine Product Overview
10.16.3 Sinovac Biological Inactivated Vaccine Product Market Performance
10.16.4 Sinovac Business Overview
10.16.5 Sinovac Recent Developments
10.17 Kangtai Biological
10.17.1 Kangtai Biological Basic Information
10.17.2 Kangtai Biological Biological Inactivated Vaccine Product Overview
10.17.3 Kangtai Biological Biological Inactivated Vaccine Product Market Performance
10.17.4 Kangtai Biological Business Overview
10.17.5 Kangtai Biological Recent Developments
10.18 Zhifei Biological
10.18.1 Zhifei Biological Basic Information
10.18.2 Zhifei Biological Biological Inactivated Vaccine Product Overview
10.18.3 Zhifei Biological Biological Inactivated Vaccine Product Market Performance
10.18.4 Zhifei Biological Business Overview
10.18.5 Zhifei Biological Recent Developments
10.19 AIM Vaccine
10.19.1 AIM Vaccine Basic Information
10.19.2 AIM Vaccine Biological Inactivated Vaccine Product Overview
10.19.3 AIM Vaccine Biological Inactivated Vaccine Product Market Performance
10.19.4 AIM Vaccine Business Overview
10.19.5 AIM Vaccine Recent Developments
11 BIOLOGICAL INACTIVATED VACCINE MARKET FORECAST BY REGION
11.1 Global Biological Inactivated Vaccine Market Size Forecast
11.2 Global Biological Inactivated Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Biological Inactivated Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Biological Inactivated Vaccine Market Size Forecast by Region
11.2.4 South America Biological Inactivated Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Biological Inactivated Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Biological Inactivated Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Biological Inactivated Vaccine by Type (2026-2035)
12.1.2 Global Biological Inactivated Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Biological Inactivated Vaccine by Type (2026-2035)
12.2 Global Biological Inactivated Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Biological Inactivated Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Biological Inactivated Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Biological Inactivated Vaccine Market Size by Type (M USD)
Table 4. Global Biological Inactivated Vaccine Market Size by Application
Table 5. Biological Inactivated Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Biological Inactivated Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Biological Inactivated Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Biological Inactivated Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Biological Inactivated Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Inactivated Vaccine as of 2025)
Table 11. Global Market Biological Inactivated Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Biological Inactivated Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biological Inactivated Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Biological Inactivated Vaccine Sales by Type (K MT)
Table 27. Global Biological Inactivated Vaccine Market Size by Type (M USD)
Table 28. Global Biological Inactivated Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Biological Inactivated Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Biological Inactivated Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Biological Inactivated Vaccine Market Share by Type (2020-2025)
Table 32. Global Biological Inactivated Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Biological Inactivated Vaccine Sales (K MT) by Application
Table 34. Global Biological Inactivated Vaccine Market Size by Application
Table 35. Global Biological Inactivated Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Biological Inactivated Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Biological Inactivated Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Biological Inactivated Vaccine Market Share by Application (2020-2025)
Table 39. Global Biological Inactivated Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Biological Inactivated Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Biological Inactivated Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Biological Inactivated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Biological Inactivated Vaccine Market Size by Region (2020-2025)
Table 44. North America Biological Inactivated Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Biological Inactivated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Biological Inactivated Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Biological Inactivated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Biological Inactivated Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Biological Inactivated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Biological Inactivated Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Biological Inactivated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Biological Inactivated Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Biological Inactivated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Biological Inactivated Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Biological Inactivated Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Biological Inactivated Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Biological Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Biological Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Biological Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Biological Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Biological Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Biological Inactivated Vaccine Product Overview
Table 64. Sanofi Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. GSK Basic Information
Table 69. GSK Biological Inactivated Vaccine Product Overview
Table 70. GSK Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. Merck Basic Information
Table 75. Merck Biological Inactivated Vaccine Product Overview
Table 76. Merck Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Merck Business Overview
Table 78. Merck SWOT Analysis
Table 79. Merck Recent Developments
Table 80. Pfizer Basic Information
Table 81. Pfizer Biological Inactivated Vaccine Product Overview
Table 82. Pfizer Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Pfizer Business Overview
Table 84. Pfizer Recent Developments
Table 85. SII Basic Information
Table 86. SII Biological Inactivated Vaccine Product Overview
Table 87. SII Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. SII Business Overview
Table 89. SII Recent Developments
Table 90. Valneva Basic Information
Table 91. Valneva Biological Inactivated Vaccine Product Overview
Table 92. Valneva Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Valneva Business Overview
Table 94. Valneva Recent Developments
Table 95. Bharat Biotech Basic Information
Table 96. Bharat Biotech Biological Inactivated Vaccine Product Overview
Table 97. Bharat Biotech Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Bharat Biotech Business Overview
Table 99. Bharat Biotech Recent Developments
Table 100. KM Biologics Basic Information
Table 101. KM Biologics Biological Inactivated Vaccine Product Overview
Table 102. KM Biologics Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. KM Biologics Business Overview
Table 104. KM Biologics Recent Developments
Table 105. Baxter Basic Information
Table 106. Baxter Biological Inactivated Vaccine Product Overview
Table 107. Baxter Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Baxter Business Overview
Table 109. Baxter Recent Developments
Table 110. Bio Farma Basic Information
Table 111. Bio Farma Biological Inactivated Vaccine Product Overview
Table 112. Bio Farma Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Bio Farma Business Overview
Table 114. Bio Farma Recent Developments
Table 115. IVAC Basic Information
Table 116. IVAC Biological Inactivated Vaccine Product Overview
Table 117. IVAC Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. IVAC Business Overview
Table 119. IVAC Recent Developments
Table 120. Takeda Basic Information
Table 121. Takeda Biological Inactivated Vaccine Product Overview
Table 122. Takeda Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Takeda Business Overview
Table 124. Takeda Recent Developments
Table 125. Emergent BioSolutions Basic Information
Table 126. Emergent BioSolutions Biological Inactivated Vaccine Product Overview
Table 127. Emergent BioSolutions Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Emergent BioSolutions Business Overview
Table 129. Emergent BioSolutions Recent Developments
Table 130. Sinergium Biotech Basic Information
Table 131. Sinergium Biotech Biological Inactivated Vaccine Product Overview
Table 132. Sinergium Biotech Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Sinergium Biotech Business Overview
Table 134. Sinergium Biotech Recent Developments
Table 135. China Biotechnology Basic Information
Table 136. China Biotechnology Biological Inactivated Vaccine Product Overview
Table 137. China Biotechnology Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. China Biotechnology Business Overview
Table 139. China Biotechnology Recent Developments
Table 140. Sinovac Basic Information
Table 141. Sinovac Biological Inactivated Vaccine Product Overview
Table 142. Sinovac Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Sinovac Business Overview
Table 144. Sinovac Recent Developments
Table 145. Kangtai Biological Basic Information
Table 146. Kangtai Biological Biological Inactivated Vaccine Product Overview
Table 147. Kangtai Biological Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Kangtai Biological Business Overview
Table 149. Kangtai Biological Recent Developments
Table 150. Zhifei Biological Basic Information
Table 151. Zhifei Biological Biological Inactivated Vaccine Product Overview
Table 152. Zhifei Biological Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Zhifei Biological Business Overview
Table 154. Zhifei Biological Recent Developments
Table 155. AIM Vaccine Basic Information
Table 156. AIM Vaccine Biological Inactivated Vaccine Product Overview
Table 157. AIM Vaccine Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. AIM Vaccine Business Overview
Table 159. AIM Vaccine Recent Developments
Table 160. Global Biological Inactivated Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 161. Global Biological Inactivated Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 162. North America Biological Inactivated Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 163. North America Biological Inactivated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 164. Europe Biological Inactivated Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 165. Europe Biological Inactivated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 166. Asia Pacific Biological Inactivated Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 167. Asia Pacific Biological Inactivated Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 168. South America Biological Inactivated Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 169. South America Biological Inactivated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 170. Middle East and Africa Biological Inactivated Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 171. Middle East and Africa Biological Inactivated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 172. Global Biological Inactivated Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 173. Global Biological Inactivated Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 174. Global Biological Inactivated Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 175. Global Biological Inactivated Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 176. Global Biological Inactivated Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Biological Inactivated Vaccine Market Size by Type (M USD)
Table 4. Global Biological Inactivated Vaccine Market Size by Application
Table 5. Biological Inactivated Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Biological Inactivated Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Biological Inactivated Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Biological Inactivated Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Biological Inactivated Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Inactivated Vaccine as of 2025)
Table 11. Global Market Biological Inactivated Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Biological Inactivated Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biological Inactivated Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Biological Inactivated Vaccine Sales by Type (K MT)
Table 27. Global Biological Inactivated Vaccine Market Size by Type (M USD)
Table 28. Global Biological Inactivated Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Biological Inactivated Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Biological Inactivated Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Biological Inactivated Vaccine Market Share by Type (2020-2025)
Table 32. Global Biological Inactivated Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Biological Inactivated Vaccine Sales (K MT) by Application
Table 34. Global Biological Inactivated Vaccine Market Size by Application
Table 35. Global Biological Inactivated Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Biological Inactivated Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Biological Inactivated Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Biological Inactivated Vaccine Market Share by Application (2020-2025)
Table 39. Global Biological Inactivated Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Biological Inactivated Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Biological Inactivated Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Biological Inactivated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Biological Inactivated Vaccine Market Size by Region (2020-2025)
Table 44. North America Biological Inactivated Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Biological Inactivated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Biological Inactivated Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Biological Inactivated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Biological Inactivated Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Biological Inactivated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Biological Inactivated Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Biological Inactivated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Biological Inactivated Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Biological Inactivated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Biological Inactivated Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Biological Inactivated Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Biological Inactivated Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Biological Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Biological Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Biological Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Biological Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Biological Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Biological Inactivated Vaccine Product Overview
Table 64. Sanofi Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. GSK Basic Information
Table 69. GSK Biological Inactivated Vaccine Product Overview
Table 70. GSK Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. Merck Basic Information
Table 75. Merck Biological Inactivated Vaccine Product Overview
Table 76. Merck Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Merck Business Overview
Table 78. Merck SWOT Analysis
Table 79. Merck Recent Developments
Table 80. Pfizer Basic Information
Table 81. Pfizer Biological Inactivated Vaccine Product Overview
Table 82. Pfizer Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Pfizer Business Overview
Table 84. Pfizer Recent Developments
Table 85. SII Basic Information
Table 86. SII Biological Inactivated Vaccine Product Overview
Table 87. SII Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. SII Business Overview
Table 89. SII Recent Developments
Table 90. Valneva Basic Information
Table 91. Valneva Biological Inactivated Vaccine Product Overview
Table 92. Valneva Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Valneva Business Overview
Table 94. Valneva Recent Developments
Table 95. Bharat Biotech Basic Information
Table 96. Bharat Biotech Biological Inactivated Vaccine Product Overview
Table 97. Bharat Biotech Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Bharat Biotech Business Overview
Table 99. Bharat Biotech Recent Developments
Table 100. KM Biologics Basic Information
Table 101. KM Biologics Biological Inactivated Vaccine Product Overview
Table 102. KM Biologics Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. KM Biologics Business Overview
Table 104. KM Biologics Recent Developments
Table 105. Baxter Basic Information
Table 106. Baxter Biological Inactivated Vaccine Product Overview
Table 107. Baxter Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Baxter Business Overview
Table 109. Baxter Recent Developments
Table 110. Bio Farma Basic Information
Table 111. Bio Farma Biological Inactivated Vaccine Product Overview
Table 112. Bio Farma Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Bio Farma Business Overview
Table 114. Bio Farma Recent Developments
Table 115. IVAC Basic Information
Table 116. IVAC Biological Inactivated Vaccine Product Overview
Table 117. IVAC Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. IVAC Business Overview
Table 119. IVAC Recent Developments
Table 120. Takeda Basic Information
Table 121. Takeda Biological Inactivated Vaccine Product Overview
Table 122. Takeda Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Takeda Business Overview
Table 124. Takeda Recent Developments
Table 125. Emergent BioSolutions Basic Information
Table 126. Emergent BioSolutions Biological Inactivated Vaccine Product Overview
Table 127. Emergent BioSolutions Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Emergent BioSolutions Business Overview
Table 129. Emergent BioSolutions Recent Developments
Table 130. Sinergium Biotech Basic Information
Table 131. Sinergium Biotech Biological Inactivated Vaccine Product Overview
Table 132. Sinergium Biotech Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Sinergium Biotech Business Overview
Table 134. Sinergium Biotech Recent Developments
Table 135. China Biotechnology Basic Information
Table 136. China Biotechnology Biological Inactivated Vaccine Product Overview
Table 137. China Biotechnology Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. China Biotechnology Business Overview
Table 139. China Biotechnology Recent Developments
Table 140. Sinovac Basic Information
Table 141. Sinovac Biological Inactivated Vaccine Product Overview
Table 142. Sinovac Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Sinovac Business Overview
Table 144. Sinovac Recent Developments
Table 145. Kangtai Biological Basic Information
Table 146. Kangtai Biological Biological Inactivated Vaccine Product Overview
Table 147. Kangtai Biological Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Kangtai Biological Business Overview
Table 149. Kangtai Biological Recent Developments
Table 150. Zhifei Biological Basic Information
Table 151. Zhifei Biological Biological Inactivated Vaccine Product Overview
Table 152. Zhifei Biological Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Zhifei Biological Business Overview
Table 154. Zhifei Biological Recent Developments
Table 155. AIM Vaccine Basic Information
Table 156. AIM Vaccine Biological Inactivated Vaccine Product Overview
Table 157. AIM Vaccine Biological Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. AIM Vaccine Business Overview
Table 159. AIM Vaccine Recent Developments
Table 160. Global Biological Inactivated Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 161. Global Biological Inactivated Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 162. North America Biological Inactivated Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 163. North America Biological Inactivated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 164. Europe Biological Inactivated Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 165. Europe Biological Inactivated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 166. Asia Pacific Biological Inactivated Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 167. Asia Pacific Biological Inactivated Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 168. South America Biological Inactivated Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 169. South America Biological Inactivated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 170. Middle East and Africa Biological Inactivated Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 171. Middle East and Africa Biological Inactivated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 172. Global Biological Inactivated Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 173. Global Biological Inactivated Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 174. Global Biological Inactivated Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 175. Global Biological Inactivated Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 176. Global Biological Inactivated Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Biological Inactivated Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biological Inactivated Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Biological Inactivated Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Biological Inactivated Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biological Inactivated Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Biological Inactivated Vaccine Product Life Cycle
Figure 13. Biological Inactivated Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Biological Inactivated Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Biological Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Biological Inactivated Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Biological Inactivated Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Biological Inactivated Vaccine
Figure 19. Global Biological Inactivated Vaccine Market PEST Analysis
Figure 20. Global Biological Inactivated Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Biological Inactivated Vaccine Market Share by Type
Figure 27. Sales Market Share of Biological Inactivated Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Biological Inactivated Vaccine by Type in 2025
Figure 29. Market Share of Biological Inactivated Vaccine by Type (2020-2025)
Figure 30. Market Share of Biological Inactivated Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Biological Inactivated Vaccine Market Share by Application
Figure 33. Global Biological Inactivated Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Biological Inactivated Vaccine Sales Market Share by Application in 2025
Figure 35. Global Biological Inactivated Vaccine Market Share by Application (2020-2025)
Figure 36. Global Biological Inactivated Vaccine Market Share by Application in 2025
Figure 37. Global Biological Inactivated Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Biological Inactivated Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Biological Inactivated Vaccine Market Size by Region (2020-2025)
Figure 40. North America Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Biological Inactivated Vaccine Sales Market Share by Country in 2024
Figure 43. North America Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Biological Inactivated Vaccine Market Size by Country in 2024
Figure 45. U.S. Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Biological Inactivated Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Biological Inactivated Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Biological Inactivated Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Biological Inactivated Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Biological Inactivated Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Biological Inactivated Vaccine Market Size by Country in 2024
Figure 55. Germany Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Biological Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Biological Inactivated Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Biological Inactivated Vaccine Market Size by Region in 2024
Figure 68. China Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Biological Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Biological Inactivated Vaccine Sales Market Share by Country in 2024
Figure 80. South America Biological Inactivated Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Biological Inactivated Vaccine Market Size by Country in 2024
Figure 82. Brazil Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Biological Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Biological Inactivated Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Biological Inactivated Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Biological Inactivated Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Biological Inactivated Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Biological Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Biological Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Biological Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Biological Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Biological Inactivated Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Biological Inactivated Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Biological Inactivated Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Biological Inactivated Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Biological Inactivated Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Biological Inactivated Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Biological Inactivated Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biological Inactivated Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Biological Inactivated Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Biological Inactivated Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biological Inactivated Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Biological Inactivated Vaccine Product Life Cycle
Figure 13. Biological Inactivated Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Biological Inactivated Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Biological Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Biological Inactivated Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Biological Inactivated Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Biological Inactivated Vaccine
Figure 19. Global Biological Inactivated Vaccine Market PEST Analysis
Figure 20. Global Biological Inactivated Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Biological Inactivated Vaccine Market Share by Type
Figure 27. Sales Market Share of Biological Inactivated Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Biological Inactivated Vaccine by Type in 2025
Figure 29. Market Share of Biological Inactivated Vaccine by Type (2020-2025)
Figure 30. Market Share of Biological Inactivated Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Biological Inactivated Vaccine Market Share by Application
Figure 33. Global Biological Inactivated Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Biological Inactivated Vaccine Sales Market Share by Application in 2025
Figure 35. Global Biological Inactivated Vaccine Market Share by Application (2020-2025)
Figure 36. Global Biological Inactivated Vaccine Market Share by Application in 2025
Figure 37. Global Biological Inactivated Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Biological Inactivated Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Biological Inactivated Vaccine Market Size by Region (2020-2025)
Figure 40. North America Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Biological Inactivated Vaccine Sales Market Share by Country in 2024
Figure 43. North America Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Biological Inactivated Vaccine Market Size by Country in 2024
Figure 45. U.S. Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Biological Inactivated Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Biological Inactivated Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Biological Inactivated Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Biological Inactivated Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Biological Inactivated Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Biological Inactivated Vaccine Market Size by Country in 2024
Figure 55. Germany Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Biological Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Biological Inactivated Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Biological Inactivated Vaccine Market Size by Region in 2024
Figure 68. China Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Biological Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Biological Inactivated Vaccine Sales Market Share by Country in 2024
Figure 80. South America Biological Inactivated Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Biological Inactivated Vaccine Market Size by Country in 2024
Figure 82. Brazil Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Biological Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Biological Inactivated Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Biological Inactivated Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Biological Inactivated Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Biological Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Biological Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Biological Inactivated Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Biological Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Biological Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Biological Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Biological Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Biological Inactivated Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Biological Inactivated Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Biological Inactivated Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Biological Inactivated Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Biological Inactivated Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Biological Inactivated Vaccine Market Share Forecast by Application (2026-2035)
